The Impact of Art Therapy on the Relationships Between Individuals Diagnosed With Alzheimer's Disease and Their Care Partners

December 5, 2024 updated by: Wake Forest University Health Sciences
The purpose of this study is to evaluate the impact of a 4-week art therapy intervention on the relationships between individuals diagnosed with Alzheimer's disease and their care partners, on the self-esteem of diagnosed individuals, and on care partner attitudes towards persons with Alzheimer's disease.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The aim is to develop and implement an art therapy intervention for dyads - each consisting of an individual diagnosed with mild Alzheimer's disease and his/her care partner - with the goals of improving patients' and care partners' sense of their relationship, increasing patients' self-esteem and improving care partner attitudes towards individuals with Alzheimer's disease. The specific intervention will be a portrait-making project utilizing a collage approach. Each participant (i.e. diagnosed individuals and care partners) will be instructed to create a portrait of him/herself. Participants will be provided with a sample portrait as well as bins of materials (e.g. words, images, markers). The intervention will be administered for 1 ½ hours weekly, at the same day/time, for 4 consecutive weeks.

Study Type

Interventional

Enrollment (Actual)

82

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Park Ridge, Illinois, United States, 60068
        • Advocate Memory Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion criteria for patients include:

  • A diagnosis of Alzheimer's disease, based on the NIA/AA Diagnostic Guidelines for Alzheimer's Disease (McKhann et al., 2011)
  • MMSE of 18-26, inclusive, administered within 6 month prior to screening or at screening
  • Awareness of diagnosis and/or memory impairment, as determined by semi-structured interview with clinician (see Appendix B)
  • Availability and willingness to participate in all 4 sessions of the intervention
  • A care partner with whom the patient has regular weekly contact and who is available and willing to participate in all 4 sessions of the intervention
  • Sufficient visual acuity to read 12-point font
  • Sufficient manual dexterity to use scissors
  • Ability to hear instructions in a classroom setting
  • Ability to read English
  • Age 18 years old or greater

Exclusion criteria for patients include:

  • Any uncontrolled medical or neurological/neurodegenerative condition (other than AD) that, in the opinion of the Investigator, might be a contributing cause of the subject's cognitive impairment (e.g., substance abuse, vitamin B12 deficiency, abnormal thyroid function, stroke or other cerebrovascular condition, Lewy body dementia, fronto-temporal dementia, head trauma).
  • Current active psychiatric illness (e.g., major depression, schizophrenia, etc.)
  • Current active seizure disorder.
  • Malignancy or carcinoma currently requiring active treatment or progressing off of treatment.
  • Recent history (within 1 year) of alcohol abuse or drug abuse.
  • Active tobacco use that interferes with visits (e.g., if the patient would need to smoke during the therapy session).
  • Use of medications (e.g., narcotics, sedatives, etc.) that lead to drowsiness during the therapy sessions
  • Inability to comply with the instructions of the art therapist.
  • Other unspecified reasons that, in the opinion of the Investigator make the subject unsuitable for enrollment.
  • Prisoners

Inclusion criteria for care partners include:

  • Adult 18 years of age or older
  • Ability to consent
  • Regular weekly contact with the subject diagnosed with Alzheimer's disease
  • Availability and willingness to participate in all 4 sessions of the intervention
  • Sufficient visual acuity to read 12-point font
  • Sufficient manual dexterity to use scissors
  • Ability to hear instructions in a classroom setting
  • Ability to read English

Exclusion criteria for care partners include:

  • Any uncontrolled medical or neurological/neurodegenerative condition sufficient to cause cognitive impairment
  • Current active psychiatric illness (e.g., major depression, schizophrenia, etc.)
  • Current active seizure disorder.
  • Malignancy or carcinoma currently requiring active treatment or progressing off of treatment.
  • Recent history (within 1 year) of alcohol abuse or drug abuse.
  • Active tobacco use that interferes with visits (e.g., if the care partner would need to smoke during the therapy session).

Use of medications (e.g., narcotics, sedatives, etc.) that lead to drowsiness during the therapy sessions

  • Inability to comply with the instructions of the art therapist.
  • Other unspecified reasons that, in the opinion of the Investigator make the care partner unsuitable for enrollment.
  • Prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dementia Participants and Care Partners
Dyads including a participant diagnosed with dementia and the care partner
Dyads will take part in a portrait-making project utilizing a collage approach. Each participant (i.e. dementia diagnosed individuals and care partners) will be instructed to create a portrait of him/herself. Participants will be provided with a sample portrait as well as bins of materials. ]The intervention will be administered for 1 ½ hours weekly, at the same day/time, for 4 consecutive weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact of Art Therapy on Quality of Dyadic Relationship
Time Frame: Week 1
Impact of art therapy on quality of dyadic relationship will be determined using the Dyadic Relationship Scale. The survey consists of 10 questions with a total score range of 10-40. The score is a measure of patient and care partner perceptions of their relationship. Lower scores indicate the perception of a poorer relationship (i.e. greater strain, lower positive interactions) and higher scores indicate a perceived better relationship (i.e. lower strain, greater positive interactions).
Week 1
Impact of Art Therapy on Quality of Dyadic Relationship
Time Frame: Week 4
Impact of art therapy on quality of dyadic relationship will be determined using the Dyadic Relationship Scale. The survey consists of 10 questions with a total score range of 10-40. The score is a measure of patient and care partner perceptions of their relationship. Lower scores indicate the perception of a poorer relationship (i.e. greater strain, lower positive interactions) and higher scores indicate a perceived better relationship (i.e. lower strain, greater positive interactions).
Week 4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact of Art Therapy on Dementia Individuals' Self-esteem
Time Frame: Week 1
The impact of art therapy on the dementia diagnosed individuals' self-esteem will be determined by the Rosenberg Self-Esteem Scale. The survey consists of 10 questions with a total score range of 0-30. The score is a measure of patient self-esteem, with lower scores meaning lower self-esteem and higher scores meaning higher self-esteem.
Week 1
Impact of Art Therapy on Dementia Individuals' Self-esteem
Time Frame: Week 4
The impact of art therapy on the dementia diagnosed individuals' self-esteem will be determined by the Rosenberg Self-Esteem Scale. The survey consists of 10 questions with a total score range of 0-30. The score is a measure of patient self-esteem, with lower scores meaning lower self-esteem and higher scores meaning higher self-esteem.
Week 4
Impact of Art Therapy on Dementia Individuals' Sense of Stigma
Time Frame: Week 1
The impact of art therapy on diagnosed individuals' sense of stigma will be determined by the Stigma Impact Scale. The survey consists of 20 questions with a total score range of 0-80. The score is a measure of the patient's perception of stigma, with lower scores indicating lower perceived stigma and higher scores indicating greater perceived stigma.
Week 1
Impact of Art Therapy on Dementia Individuals' Sense of Stigma
Time Frame: Week 4
The impact of art therapy on diagnosed individuals' sense of stigma will be determined by the Stigma Impact Scale. The survey consists of 20 questions with a total score range of 0-80. The score is a measure of the patient's perception of stigma, with lower scores indicating lower perceived stigma and higher scores indicating greater perceived stigma.
Week 4
Impact of Art Therapy on Care Partner Attitudes Towards Persons with Dementia
Time Frame: Week 1
The impact of art therapy on care partner attitudes towards persons with dementia will be determined by the Dementia Attitudes Scale. The survey consists of 20 questions with a total score range of 20-140. The score is a measure of care partner attitudes towards patients with dementia. Lower scores indicate lower knowledge and social comfort with persons with dementia and a higher score indicates greater knowledge and social comfort with persons with dementia.
Week 1
Impact of Art Therapy on Care Partner Attitudes Towards Persons with Dementia
Time Frame: Week 4
The impact of art therapy on care partner attitudes towards persons with dementia will be determined by the Dementia Attitudes Scale. The survey consists of 20 questions with a total score range of 20-140. The score is a measure of care partner attitudes towards patients with dementia. Lower scores indicate lower knowledge and social comfort with persons with dementia and a higher score indicates greater knowledge and social comfort with persons with dementia.
Week 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Darren Gitelman, MD, Wake Forest University Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 26, 2016

Primary Completion (Actual)

August 2, 2022

Study Completion (Actual)

August 2, 2022

Study Registration Dates

First Submitted

December 5, 2024

First Submitted That Met QC Criteria

December 5, 2024

First Posted (Estimated)

December 10, 2024

Study Record Updates

Last Update Posted (Estimated)

December 10, 2024

Last Update Submitted That Met QC Criteria

December 5, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00106942
  • 6409 (Other Identifier: Advocate Health Care)
  • 2016-102 (Other Grant/Funding Number: James R. and Helen D. Russell Center for Research and Innovation)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Art Therapy

Subscribe